OTCMKTS:ECTE Echo Therapeutics (ECTE) Stock Price, News & Analysis → Elon’s New A.I. Device is About to Shock the World (From InvestorPlace) (Ad) Free ECTE Stock Alerts $0.0002 0.00 (0.00%) (As of 09/7/2021) Add Compare Share Share Today's Range$0.0002▼$0.000250-Day Range N/A52-Week Range$0.00▼$0.28VolumeN/AAverage Volume54,243 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Echo Therapeutics alerts: Email Address Ad InvestorPlaceElon’s New A.I. Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. About Echo Therapeutics Stock (OTCMKTS:ECTE)Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ.Read More ECTE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ECTE Stock News HeadlinesDecember 9, 2023 | bbc.co.ukWhat are echo chambers?December 3, 2023 | investing.comECTE/USD Synthetic Historical DataApril 29, 2024 | InvestorPlace (Ad)Elon’s New A.I. Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” October 18, 2023 | investing.comECTE Historical DataJuly 11, 2023 | cnet.comBest Smart Speakers for 2023: We Tested Alexa, Google, Apple and MoreJanuary 11, 2023 | usatoday.comIn echo of Jan. 6 attack in U.S., Brazilian protesters storm their Congress, high court and palaceNovember 28, 2022 | yahoo.comNow is the time to buy an Echo Dot smart speaker on Amazon — prices start at just $14.99, and the newest model is under $40!November 24, 2022 | yahoo.comEvery Single Echo Dot Black Friday Deal Happening Right NowApril 29, 2024 | InvestorPlace (Ad)Elon’s New A.I. Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” October 11, 2022 | cnet.comYou Should Buy the 4th-Gen Echo Dot This Prime Day, Not the New One. Here's WhyJune 1, 2022 | yahoo.comEverything we know about how to watch Marvel’s ‘Echo’ on Disney+August 9, 2021 | barrons.comEcho Therapeutics Inc.See More Headlines Receive ECTE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Echo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/12/2016Today4/29/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolOTCMKTS:ECTE Previous SymbolNASDAQ:ECTE CUSIPN/A CIK1031927 Webwww.echotx.com Phone(732) 201-4194Fax215-717-4109Employees17Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesAlan Wayne SchoenbartChief Financial OfficerKey CompetitorsADM Tronics UnlimitedOTCMKTS:ADMTAksysOTCMKTS:AKSYGetinge AB (publ)OTCMKTS:GNGBYHeart TronicsOTCMKTS:HRTTIMRISOTCMKTS:IMRSQView All Competitors ECTE Stock Analysis - Frequently Asked Questions How have ECTE shares performed in 2024? Echo Therapeutics' stock was trading at $0.0002 at the beginning of the year. Since then, ECTE shares have increased by 0.0% and is now trading at $0.0002. View the best growth stocks for 2024 here. How were Echo Therapeutics' earnings last quarter? Echo Therapeutics, Inc. (OTCMKTS:ECTE) announced its earnings results on Friday, August, 12th. The medical device company reported ($0.82) earnings per share for the quarter. During the same period in the prior year, the business earned ($0.97) EPS. What other stocks do shareholders of Echo Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Echo Therapeutics investors own include Biocept (BIOC), DexCom (DXCM), Rexahn Pharmaceuticals (REXN), Acer Therapeutics (ACER), Athersys (ATHX), LadRx (CYTR), Glu Mobile (GLUU), InterCloud Systems (ICLD), NetApp (NTAP) and How do I buy shares of Echo Therapeutics? Shares of ECTE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:ECTE) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsAI finds its first serious applicationWall Street StarThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Echo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
